Databases for Congenital Heart Defect Public Health Studies Across the Lifespan by Riehle‐colarusso, Tiffany J. et al.
Databases for Congenital Heart Defect Public Health Studies Across
the Lifespan
Tiffany J. Riehle-Colarusso, MD, MPH; Lisa Bergersen, MD, MPH; Craig S. Broberg, MD, MCR; Cynthia H. Cassell, PhD; Darryl T. Gray,
MD, ScD; Scott D. Grosse, PhD; Jeffrey P. Jacobs, MD; Marshall L. Jacobs, MD; Russell S. Kirby, PhD, MS; Lazaros Kochilas, MD, MSCR;
Asha Krishnaswamy, BEE, MS; Arianne Marelli, MD, MPH; Sara K. Pasquali, MD, MHS; Thalia Wood, MPH; Matthew E. Oster, MD, MPH for
the Congenital Heart Public Health Consortium*
I n a 2012 meeting at the Centers for Disease Control andPrevention (CDC), key experts and stakeholders identified
public health knowledge gaps about congenital heart defects
(CHDs), namely prevalence of CHDs across the life span, long-
term outcomes of persons with CHDs, and health services
delivery for persons with CHDs.1 These gaps, and strategies
to address them, formed the basis of a CHD public health
science agenda. The strategies included leveraging
information in existing databases to examine the epidemiol-
ogy, health outcomes, and health service utilization of the
CHD population.1 Many databases with CHD data exist and
are managed by hospitals, specialty organizations, partner-
ships, and public health and other governmental entities.
Researchers may be familiar with some databases but not
others. Anyone planning studies to address public health
knowledge gaps may benefit from an understanding of this
complex constellation of databases.
The Congenital Heart Public Health Consortium (CHPHC)
was formed in 2009 as a collaboration of stakeholders with its
mission to prevent CHDs and improve outcomes for affected
individuals.2 The CHPHC created a database workgroup to
increase awareness of opportunities to contribute to the
public health science agenda for CHDs using existing
databases. The workgroup, consisting of experts in various
disciplines (cardiologists, surgeons, epidemiologists, health
service researchers), identified databases located in Canada
or the United States (US) with information on CHDs from
1990 onward. The goals of this article are to provide an
overview of database types and to list examples of databases
that may be used to address CHD public health knowledge
gaps. IRB approval was not deemed necessary for this review.
Database characteristics that may be important to con-
sider when designing a study to address CHD public health
knowledge gaps can be grouped into 3 main areas: (1)
population included, (2) data content, and (3) accessibility.
The first area relates to aspects such as sample size, inclusion
criteria, whether the database is population-based, and
whether persons are followed for a period of time. The
second relates to what variables are included (eg, type and
amount of clinical detail, information on resource utilization,
or financial information), data collection mechanisms and
coding, and data timeliness, accuracy, and completeness. The
last area involves obtaining access to use the data, which may
be costly, time consuming, or restricted, and will vary
depending on the database selected.
Using existing data is often more cost effective and
reasonable than gathering new data; however, research is
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CONTEMPORARY REVIEW
limited to the data that are available, and there is often no
perfect data set to answer a particular question. Features of
particular databases vary in importance, depending on the
research question. One database’s strength in answering a
question may be a limitation for another question. For
example, a database may be population-based but have
limited clinical detail. This database may be good for an
overall prevalence estimate but not as useful for analyzing
treatment outcomes of a particular CHD phenotype. It is the
role of the researcher to determine which characteristics are
most important and to find the appropriate database that will
best inform the particular research question. This article does
not comment on the strengths or weaknesses of specific
databases but, rather, presents general information and
additional resources. Researchers may use this information
to help determine the utility of existing databases for their
particular CHD public health study.
Database Categories and Examples
We grouped examples of databases into categories based on
type of data source (administrative healthcare, birth defect
surveillance, clinical, survey, and vital records). We briefly
describe each category below, with a discussion of strengths
and limitations to consider when addressing public health
knowledge gaps. We also determined whether identified
example databases had individuals with only CHDs (cardiac-
specific databases) or had individuals with many conditions,
including CHDs (general databases). Examples of cardiac-
specific and general databases in each of these categories are
listed in Tables 1 through 4. Some databases have more than
one type of data source and are therefore listed in Table 5
under a separate combined category heading (eg, Adminis-
trative and Clinical). The tables provide a brief description of
the database, sponsoring organization, years of data, and a
URL link for further information. An asterisk denotes cardiac-
specific databases. Although basic information is provided on
a variety of databases, researchers are encouraged to contact
database hosts for further information to assess their utility.
Also, because databases are constantly evolving, other
databases not captured in these tables may be useful in
addressing a particular question.
Administrative Healthcare Databases
Administrative healthcare databases are generally developed
from facility records or health insurance claims for billing
purposes and/or to document healthcare provided; they are
typically not designed for research purposes. Most are not
specific to CHDs but still are useful for research and public
health investigations related to CHDs. We identified 13
administrative healthcare databases (1 of which is cardiac
specific) (Table 1), 2 administrative/clinical databases, and 4
administrative/survey databases (Table 5).
Facility-based administrative healthcare databases include
all patients at a certain institution, regardless of payer, and
may be able to identify a person over multiple encounters.
However, these databases do not have data on outside
resources utilized by that individual. Facility-based databases
usually include the nominal charges for the services provided,
although the provision of hospital or aggregated department-
specific cost-to-charge ratios allows the estimation of facility-
perspective costs.3 On the other hand, claims-derived
administrative healthcare databases cover healthcare use by
all enrollees in certain health plans, regardless of where the
care is received, and can follow individuals for as long as they
are plan beneficiaries. Claims databases typically include
millions of enrollees and by definition do not include
nonenrollees and the uninsured. These excluded groups may
be needed in a study, depending on the particular public
health issue being addressed. Claims-based databases cap-
ture billed charges and actual payments made, including
payments made by health plans and enrollees.
In general, administrative healthcare databases can provide
large sample sizes, detailed resource utilization, and financial
information, and are often population-based to the extent they
capture all patients in a geographic area or health plan.
However, some persons may not use the healthcare system;
thus, administrative healthcare databases may either overrep-
resent sicker patients or exclude those without access to care.
Another limitation of US administrative healthcare databases is
how data are coded. Typically, these databases use Interna-
tional Classification of Disease version 9 or 10 Clinical
Modification (ICD-9-CM, ICD-10-CM) codes, which often lack
sufficient detail to adequately characterize specific CHD
phenotypes or procedures. Hence, researchers may be limited
to investigating broad classes of CHDs or procedures. Admin-
istrative databases may also be difficult to access, because of
restrictions and license fees, and to use, due to their size and
need for strong programmers or computational power.3
One example of multi-institutional facility-based databases
is the Healthcare Cost and Utilization Project (HCUP)
database developed and managed by the Agency for Health-
care Research and Quality (AHRQ) through a public-private
partnership. The cornerstone of HCUP is facility-level inpatient
and hospital outpatient discharge data that include diagnoses
and procedure codes, admission source, discharge status,
patient demographics, expected payment source, total billed
hospital charges, estimated costs, length of stay, and specific
hospital characteristics. Hospitals provide these data on all
patients, including self-pay and uninsured patients, to state-
level entities that create state-specific hospital discharge
databases. Under Memoranda of Agreements, these entities
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voluntarily share their files with AHRQ, and these files become
part of HCUP. For 2013, the most current data year available,
48 states (accounting for 97% of the US population)
participated in HCUP.4 The states decide which data elements
are included in standardized State Inpatient Databases (SID)
and whether AHRQ can release their files directly to users. For
2013, SID files for 28 states were available directly from
AHRQ; files for the remaining states can potentially be
obtained from the state-level organizations.4 Nationally rep-
resentative databases based on aggregated SID data include
the annual Nationwide/National Inpatient Sample (NIS) and
the triennial Kids’ Inpatient Sample (KID). Other HCUP
databases that capture CHD care are listed in Table 1.
Copies of the HCUP databases can be purchased; aggregated
data from select HCUP databases are freely available online at
the HCUPnet site (http://hcupnet.ahrq.gov). Several health
service research studies have used HCUP data to assess data
on incidence, outcomes, facility costs, and factors related to
hospitalization for individuals with CHDs.5-10
Health insurance claims databases include public insurers
and proprietary insurance databases, such as Truven Health’s
MarketScan suite of databases. The MarketScan research
databases include commercial databases of employer-spon-
sored insurance, a Medicare database, and a Medicaid
database representing claims from anonymized states that
contract with Truven. MarketScan data from 2005 were
used to estimate health care use and costs for children with
CHDs.5 Over 30 states have created, or are in the process of
creating, all-payer claims databases (APCD) that combine
claims from within their state from private and public
payers.11,12 Some states have APCD data available on
request, which could be useful in assessing resource utiliza-
tion and healthcare costs for persons with CHD as well as
surveillance of those with CHDs.
AHRQ has tools that states can use to improve quality of
care for vulnerable populations. To help researchers answer
specific health service questions, lists of databases with
results for quality measures and databases from which
measures could be calculated are available online (http://
nhqrnet.ahrq.gov/inhqrdr/resources). This detailed com-
pendium has information on over 100 databases and
websites, including several listed in this article (eg, MarketS-
can, HCUP, state APCDs, and Medical Expenditure Panel Sur-
vey [MEPS]), which can guide researchers to appropriate
databases for a particular study question about CHDs.
Birth Defects Surveillance
Surveillance of infants with birth defects is a core public health
activity. Although the United States has no national birth defect
Table 2. Birth Defects Surveillance Database Examples in the United States and Canada With Data From 1990 Onward for
Potential Use in Congenital Heart Defects Public Health Investigations




defects surveillance program for
live-born infants ≤ age 1 year;
multiple data sources & linkages,
including hospital & ambulatory
discharge data, Children’s Medical
Services Florida, vital records,
other administrative and clinical
data





surveillance program for live-born
& stillborn infants, fetuses, and
children diagnosed up to 6 years
of age born to residents of
metropolitan Atlanta, Georgia;
multiple clinical data sources with
linkage to vital records; active case
finding, review and classification of
CHDs
Centers for Disease Control
and Prevention—National









Data registry from 12 birth defect
surveillance systems (including
FBDR and MACDP) collaborating
on birth defects surveillance,
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surveillance system, most states maintain their own surveil-
lance programs, which can vary by which entity conducts the
surveillance (eg, health department), objectives, case ascer-
tainment method, age of children included, or defects included.
Surveillance data can be used for epidemiologic investiga-
tions13-15 or health services research.16-18 We presented 3
examples of birth defect surveillance databases (Table 2) and 3
in the combined category entitled Birth Defects Surveillance/
Survey (Table 5). It is beyond the scope of this article to list all
birth defect programs. However, a list of programs with links
can be found at the National Birth Defect Prevention Network
(NBDPN) website (http://www.nbdpn.org/state_programs_
and_related_lin.php). Researchers should contact specific
birth defect surveillance programs to explore opportunities to
analyze the state’s data.
The strengths of birth defects surveillance databases are
that they usually include a comprehensive, population-based
birth cohort of infants with birth defects. The NBDPN was
formed to address issues of surveillance, research, and
prevention among US birth defect programs.19 The NBDPN
has created surveillance guidelines to help standardize data
collection.19 Recently, the NBDPN developed data quality
measures and trilevel performance criteria focused on data
completeness, timeliness, and accuracy to assess strengths
and weaknesses of programs.20 This information will be used
to develop and implement national data quality standards for
birth defects surveillance. Many programs also use chart
review to validate diagnoses, obtain data from several data
sources, or use modified ICD-9-CM or ICD-10-CM codes,
which are more specific for birth defects; thus, the data
quality may be quite high. However, surveillance databases
have varied methodologies, rarely have resource utilization or
financial details unless linked to databases with that
information, and usually do not have detailed clinical data
Table 4. Survey Database Examples in the United States and Canada With Data From 1990 Onward for Potential Use in
Congenital Heart Defects Public Health Investigations
Name Brief Description Sponsoring Organization Data Years





Part of the Decennial Census
Program, it is a nationwide
continuous survey sent to a small
percentage of US households to
gather demographic, housing,
social, and economic data and
provide yearly reports




Decennial Census Survey of all US households done
every 10 years, consisting of short
and long forms. As of 2010, only
the short-form is done—the long
form replaced by the ACS. Data
are used for numerous purposes




Survey of households to estimate
use of health services, cost,
payment, & availability; surveys
have 3 components: core
household, insurance/employer,
and the medical provider







Survey of households to estimate
the amount, distribution, & effects
of illness & disability in the US
across demographics and
socioeconomic status; updated
questions on select topics; main
source of health information on the
US population









Random sample survey of
households in all states to assess
prevalence & impact of special
healthcare needs among children
in the US; survey has core &
special topic areas such as CHDs




2000, 2005, 2009 http://www.cdc.gov/nchs/
slaits/cshcn.htm
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on treatment course, unless it is related to the diagnosis of
the CHD. Furthermore, due to Health Insurance Portability and
Accountability Act (HIPAA) regulations, access to identifiable
data is restricted and governed by the birth defects program.
Birth defects surveillance databases, unless linked to other
databases to provide information beyond infancy, are not
Table 5. Combined Database Examples in the United States and Canada With Data From 1990 Onward for Potential Use in
Congenital Heart Defects Public Health Investigations
Name Brief Description Sponsoring Organization Data Years






Collaboration of 18 integrated healthcare
delivery systems implementing research
findings in clinical practice; working over a
broad scope of indicators, they aim to





Database augmenting the existing PHIS (see
Table 1) database by linking electronic
laboratory and radiology reports from 6 of
the 49 Children’s Hospital Association













National sample survey of nonfederal office-
based physicians to provide data on










National sample survey of hospital
emergency, outpatient, hospital-based, &
nonhospital ambulatory surgery centers;
provides data on care at hospital-based









Probability survey of inpatients discharged
from nonfederal short-stay US hospitals;








Survey combining data from NHAMCS,












study of 17 birth defects, building on
findings from the NBDPS (see below)







study of 30 birth defects; includes
maternal interview & cheek cell specimens
from family members; excludes
syndromes & chromosomal abnormalities






Multisite case-control study of birth defects
& newborn health; focuses on
environmental exposures (primarily
medications) in pregnancy; includes
maternal interview, medical record





*Centers for Disease Control and Prevention.
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longitudinal. Although birth defects surveillance databases
may not be able to address some clinical or outcomes
questions, their strengths provide important information on
the birth prevalence of CHDs.
One of the oldest birth defects surveillance programs is the
Metropolitan Atlanta Congenital Defects Program (MACDP),
maintained by the Centers for Disease Control and Preven-
tion. Begun in 1967, MACDP collects information on birth
defects in infants and children up to 6 years of age who were
born to mothers residing in select metropolitan Atlanta
counties.21 Cases are identified by trained abstractors who
actively search newborn hospitals, pediatric hospitals, and
other clinical sources, and cases are linked to vital records
from the Georgia Department of Public Health. Records are
reviewed, and those with a CHD diagnostic code are classified
by physicians trained in pediatric cardiology, using standard
clinical nomenclature derived from the Society of Thoracic
Surgeons Congenital Heart Surgery Database (STS-CHSD).22
MACDP data on CHDs have been extensively analyzed,
resulting in publications on trends in prevalence and
survival,13,15,23 risk factors for CHDs,24 and a comparison of
administrative and clinical coding for CHDs.25
Birth defects surveillance programs monitor the CHD
occurrence in their jurisdiction and contribute to CHD
epidemiology. However, given the rarity of birth defects,
there are often insufficient data in any one state to address
some public health questions. The NBDPN also publishes
pooled data from participating programs; in the 2012 annual
report critical CHD surveillance data were highlighted,26 and
the public health role in newborn screening for critical CHDs
was discussed.27 There is also a data repository with data
submitted by several states for infants with birth defects born
1999-2007, which has been used to study the association of
race/ethnicity with birth defects,28 the survival of infants born
with birth defects,29,30 and may be used to study other issues
related to CHDs.
Clinical CHD Databases or Registries
Many databases with clinical information on persons with
CHDs exist, including single- and multi-institutional databases
as well as specialty care registries and research data sets.
These databases vary in years of data collected, type of data,
inclusion criteria, and purposes for utility. Research data sets
may have uniquely different characteristics from clinical
registries. Many clinical databases are designed to track
patient outcomes, to improve quality of care, or for care
benchmarking. However, since the early years of pediatric
cardiac interventions, it was recognized that the experience of
any single institution was limited, and collaboration between
centers was necessary to have sufficient numbers to conduct
meaningful outcomes analyses. In this article, we grouped
examples of multi-institutional clinical data sets, specialty
care registries, and research data sets in the “clinical”
category. We identified 15 databases sourced primarily from
clinical practice (13 cardiac-specific ones) (Table 3), and 2
administrative/clinical databases, sourced from a combina-
tion of large administrative healthcare databases combined
with clinical practice data (Table 5).
The strength of clinical databases to address public health
knowledge gaps lies in their detailed information on diagnosis,
treatment, and clinical outcomes. Multi-institutional clinical
databases usually amass a large sample size over time, with
diversity in CHD phenotypes, patient characteristics, and
geographic representation. Furthermore, clinical databases
often use standard nomenclature and outcome measures,
although the implementation of these standards may be
inconsistent within or across institutions or databases, as
recently documented.31 Clinical databases may also have
information on comorbidities and noncardiac events, which is
especially important for the older population. Clinical
databases are useful, for example, when evaluating how
clinical factors such as treatment or hospital course might
influence the long-term outcomes of persons with a particular
CHD phenotype. However, clinical databases may include only
certain cohorts (eg, only persons with a specific diagnosis or
undergoing a certain type of intervention), with little or no
longitudinal follow-up of only limited outcome variables, may
not be representative of the study population, and may not
include resource utilization or financial data. Accessing the
data may also require special approval or fee for access.
These limitations may be important if a researcher is
interested in an entire population or patient characteristics,
which may not be consistently captured in clinical data (eg,
birth information).
Efforts are ongoing to enhance and improve clinical
databases for CHDs. The Multi-Societal Database Committee
for Pediatric and Congenital Heart Disease was established in
2005 to provide infrastructure for collaboration among
healthcare professionals interested in the outcomes of
persons with CHDs.32 This committee is working to collab-
orate on use of common nomenclature, uniform core data set
information, evaluation of case complexity, development of a
mechanism for verifying case completeness and accuracy,
and standardization of protocols for longitudinal follow-up of
persons with CHDs.32 The outputs from this committee could
help address not only questions related to treatment
outcomes but public health questions as well.
One example of a large clinical database with geographical
and diagnostic diversity is the STS-CHSD, founded in 1994 to
support quality improvement in cardiothoracic surgery.33 As
of December 31, 2015, STS-CHSD contains 394 980 oper-
ations reported from 124 pediatric and congenital heart
surgery hospitals in the United States and 3 centers in
DOI: 10.1161/JAHA.116.004148 Journal of the American Heart Association 10


















Canada. With penetrance of over 95% in the United States, the
data in STS-CHSD are representative of all US pediatric and
congenital heart surgeries.33 Definitions of all terms
and codes used in the STS-CHSD have been standardized
and published, including the use of the International Pediatric
and Congenital Cardiac Code (IPCCC).34 The STS-CHSD
employs data quality measures and produces regular reports
to better understand outcomes, provide benchmarks, and
improve quality of care.32,33,35-38 Data from the STS-CHSD
have also helped fill public health knowledge gaps. Application
of the STS-CHSD nomenclature improved the quality of
surveillance data22 for subsequent population-based analyses,
eg, prevalence trends in CHDs,13 CHD survival,14,15 and receipt
of special education by those with CHD.39 As with other
clinical databases, aspects of the STS-CHSD may limit its utility
to answer some public health questions (eg, access to care).
Surveys
In surveys, individuals are usually sampled from a defined
population and queried using a structured instrument (eg,
telephone questionnaire) to generate information on a
representative sample with respect to a target population of
interest (eg, children <18 years of age). Data can be used to
profile key issues in the population of individuals with CHDs to
help set priorities for healthcare policy, develop programs,
and improve services. The utility of survey data for answering
CHD public health questions varies, depending on the survey
design, sample composition and size, timeframe, and topics or
questions included. In general, surveys that include persons
with CHDs may be large overall (ie, a nationally representative
sample) but may have a small number of total or specific CHD
phenotypes, which may limit utility of the database. We
identified several examples of databases with survey infor-
mation that may be useful in public health studies of CHDs: 5
general survey databases (Table 4), 4 administrative/survey
databases (Table 5), and 3 birth defect surveillance/survey
databases (Table 5).
A strength of the identified surveys is that they ask the
person or his or her proxy (eg, a parent) about a broad range
of topics relevant to public health (ie, medical and nonmedical
exposures, resource utilization, demographics, socioeconomic
data, care coordination, continuity of care, barriers to care).
Data important for understanding public health aspects of
CHDs, such as self-reported information on quality of life or
pregnancy exposures, may be available in survey data and not
in other types of data sources. However, survey information is
self-reported, often retrospective, and may have varying
degrees of validity and recall bias. Data from surveys are
typically cross-sectional—providing information about the
population at one point in time—which may limit generaliz-
ability of research findings. Surveys typically lack identifiers
that could otherwise be used for linking with other databases.
Although the survey may be conducted repeatedly, it is
usually on a different sample each time, as very few surveys
recontact participants to obtain longitudinal data.
Two main sources of national population-based data are
the Decennial Census and the American Community Survey
(ACS). The Decennial Census has been conducted since 1790
as required by the US Constitution. Most households receive
a short questionnaire, and prior to 2010 1 in every 6
households received a more detailed long questionnaire on
socioeconomics. After 2000, the Census Bureau redesigned
the census, and the socioeconomic questionnaire became the
ACS. The ACS surveys households monthly and provides
yearly information to communities in 1-, 3-, and 5-year
reports.40 Data and tools to use the data from these surveys
are publically available. The Census and ACS can be useful
denominator and comparison data in studies of the CHD
population. Furthermore, these data can be linked to other
databases to study community-level factors influencing health
and outcomes of persons with CHDs.
The National Survey of Children with Special Health Care
Needs (NS-CSHCN) was a telephone survey sponsored by the
federal Maternal and Child Health Bureau, designed to
periodically sample the US population to identify children
<18 years of age with special healthcare needs.41 Telephone
numbers were randomly dialed to identify households with 1
or more children <18 years of age. Trained interviewers asked
the parent or guardian questions to identify all children in the
household with special healthcare needs. It was administered
3 times between 2001 and 2010. In the 2009-2010 survey,
CHDs were a specific condition prompt. Topics covered
included child’s health and functional status, insurance
coverage, access to healthcare, care coordination, and impact
of health conditions on the child and the family.41 The survey
is being integrated into the National Survey of Children’s
Health but will still provide the same in-depth look at the lives
of children with special healthcare needs. Survey strengths
included that it was population-based and provided publicly
available comparison data sets. It described the population of
CSHCN and provided a snapshot of the impact of special
healthcare needs. However, CHDs and treatment are not
confirmed by a medical record source.
Vital Records
The US vital records system is a federal-state partnership in
which state vital records agencies receive federal funds for
providing statistical data concerning vital events (live birth,
death, and fetal death). Birth and death certificates enumerate
all live births and deaths occurring in the United States and
provide a comprehensive population-based cohort. Thus, vital
records are important in CHD public health studies. Although all
DOI: 10.1161/JAHA.116.004148 Journal of the American Heart Association 11


















states have vital records, data content varies slightly by state.
The National Center for Health Statistics (NCHS) has promul-
gated national standard certificates that define the content and
data elements.42,43 Researchers should contact the depart-
ment of health in the particular states of interest to obtain
information on available state-specific vital records databases.
Birth and death certificates contain protected personal
identifiable information. However, NCHS has national, dei-
dentified, publicly available data files (eg, birth, death, and
period-linked birth-infant death data)44 useful for public health
studies. For example, causes of death information from death
certificates were used to describe annual CHD mortality in the
United States by age, race, and sex.45 Period-linked birth-
death data were used to identify racial differences in infant
mortality due to birth defects such as CHDs.46 The NCHS also
maintains the National Death Index (NDI), a restricted-access,
centralized database of all state death records.
Although vital records data are useful, there are some
limitations to consider. The quality of birth defects reporting on
birth and fetal death certificates is generally poor and thus may
influence the quality of a particular study.47–49 Researchers
have identified limitations in ability to identify all decedents
with a specific illness or health condition.50,51 The coding on
birth or death records, or the checkboxes used on many birth/
fetal death certificates, may not provide accurate or sufficient
diagnostic details for some studies. Furthermore, birth and
death certificates may use different coding systems. Death
certificates have been coding underlying cause of death using
ICD-10 since 1999, well ahead of clinical utilization of ICD-10-
CM for billing purposes, which became official as of October 1,
2015. Resource utilization and cost/charge data are not
presently reported in these documents. Finally, due to the
personal identifying information, individual-level vital records
are not easily accessible to general researchers and often must
be linked at the health department or via the NDI.
Combining Databases Across Categories
Combining databases can maximize strengths and minimize
limitations of individual databases to address issues in ways
that may not be possible using a single database (Table 5). For
example, linking data from a clinical database (STS-CHSD) with
data from an administrative database (Pediatric Health Infor-
mation System [PHIS]) has allowed multiple studies on
healthcare utilization with robust clinical data to be con-
ducted.52-54 Leveraging existing databases through linkage is
also important to understand long-term and longitudinal
outcomes for persons with CHDs. One example is the linkage
of the Pediatric Cardiac Care Consortium (PCCC) with national
registries. The PCCC contains data on patients who have
undergone CHD interventions at 47 US centers between 1982
and 2011, with direct identifiers available for patients enrolled
up to April 2003.55 The availability of direct identifiers allowed
linkage of PCCC data with the NDI and the United Network for
Organ Sharing (UNOS), thereby providing significant informa-
tion regarding the long-term outcomes after palliative or
corrective procedures.56 These linkages may address some of
the individual database weaknesses regarding longer-term and
longitudinal follow-up. Experts across disciplines agree that
there needs to be a better mechanism for longitudinal follow-up
of persons with CHDs across the life span. Longitudinal data
can provide unique outcomes information.1,57 Restricted-
access data files, such as NDI and the corresponding state-
level records, may also be useful for other record-based linkage
studies of persons with CHDs. Birth defects surveillance data
have been linked to vital records to examine CHD prevalence13
and survival,15,58 and to longitudinal school records to inves-
tigate receipt of special education services among children with
CHDs.39 Such population-based estimates are attainable only
through linkage of multiple databases.
Throughout this article we have noted unique databases that
span 2 database categories. However, databases from different
categories have also been combined to form new stand-alone
databases. One example of a database that spans 2 categories
(ie, birth defect surveillance and surveys) is the National Birth
Defects Prevention Study (NBDPS). The NBDPS is a multisite
collaborative case-control study to evaluate potential genetic
and environmental risk factors for major congenital malforma-
tions, including CHDs.59-62 Cases of CHDs are identified from
birth defect surveillance data, and structured telephone
interviews are conducted with mothers of cases and controls.
Investigations using NBDPS data have contributed to under-
standing CHDs, including occurrence risk associated with
maternal smoking,63 obesity,64 medication use,65,66 and
descriptive epidemiologic studies of select CHDs.67,68 The
strength of studies such as the NBDPS is that they are large,
population-based, multicenter studies with standardized inter-
view protocol, medical record review, and classification of
CHDs. However, limitations exist, including potentially inaccu-
rate or biased recall of exposures of interest due to self-report.
CDC recognized the possibilities for research and surveil-
lance through linking data across various sources. In 2012,
CDC awarded grants to the New York State Department of
Health, Emory University in Atlanta, Georgia, and the
Massachusetts Department of Public Health for a pilot study
to develop population-based surveillance of adolescents and
adults with CHDs. The grantees combined data within their
states from a variety of data sources including birth defects
surveillance data, Medicaid data, hospital discharge data, vital
records, provider reports, and clinic billing data.69 As results
are being analyzed from this pilot, a new collaborative study
with 5 sites is expanding on this work.
Although examples of specific database combinations
exist, a coordinated effort to use data for answering public
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health questions concerning CHDs is lacking. The consolida-
tion of heterogeneous datasets raises significant challenges
related to confidentiality, governance, nomenclature and
coding structure, and information technology capabilities.
Even efforts at combining multi-institutional electronic health
record (EHR) data on CHD have identified many obstacles.31
For example, there are inherent complexities of database
interaction, such as nonstandard variable definitions or
database structure. Furthermore, data are from disparate
populations and different time points across the life span.
Some represent a cross-section of the population, whereas
others include only those patients seen in a specific
healthcare setting or at the time of a specific event (such
as surgery or cardiac intervention). Procedural data sets
include far more clinical detail than administrative sources.
The types of coding schemes used for each database vary, as
well as the experience of the database manager or healthcare
provider who selects the codes, both of which create inherent
heterogeneity in the accuracy and granularity of the congen-
ital diagnosis. Variables for accurate linkage between data
sets may not be adequate, although this could be assisted
through the use of a global unique identifier, as has been
endorsed by the National Institutes of Health for other groups
(https://ndar.nih.gov/tools_guid_tool.html). Furthermore,
issues of HIPAA compliance may be raised because consent
for data use in one database may not carry over to a
conglomerate. To help address these challenges, in January
2015, the National Heart, Lung, and Blood Institute (NHLBI)
convened a workgroup to develop a vision for an integrated
data network for CHD research. The subsequent report
summarizes the discussions and identifies critical elements as
well as potential barriers for integrating CHD data.57
Conclusion
There are numerous databases available to address public
health knowledge gaps about CHDs across the life span.
Databases can be grouped into broad categories with
particular strengths and limitations. Understanding the rela-
tive characteristics of different databases is important for
choosing the best data to answer a particular research
question or to identify opportunities to maximize strengths
and minimize limitations through database linkages.
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